60 Degrees Pharmaceuticals与佛罗里达州立大学达成独家期权协议,共同推进栗精胺用于蜱传疾病治疗

美股速递
Jul 08

60 Degrees Pharmaceuticals 宣布,已与佛罗里达州立大学签署一项独家期权协议,旨在共同推进化合物栗精胺(Castanospermine)用于治疗蜱传疾病的研发工作。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10